Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pegasys Plus Entecavir Versus Entecavir Versus Pegasys for Hepatitis B e Antigen-Negative Chronic Hepatitis B

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2014 by National Taiwan University Hospital
Roche Pharma AG
Information provided by (Responsible Party):
National Taiwan University Hospital Identifier:
First received: August 16, 2013
Last updated: December 3, 2014
Last verified: December 2014
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: December 2018 (Final data collection date for primary outcome measure)